121 related articles for article (PubMed ID: 894062)
1. Measurement of skin thickness: a comparison of two in vivo techniques with a conventional histometric method.
Dykes PJ; Marks R
J Invest Dermatol; 1977 Sep; 69(3):275-8. PubMed ID: 894062
[TBL] [Abstract][Full Text] [Related]
2. Radiographic measurement of topical corticosteroid-induced atrophy.
Snyder DS; Greenberg RA
J Invest Dermatol; 1977 Sep; 69(3):279-81. PubMed ID: 330766
[TBL] [Abstract][Full Text] [Related]
3. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
Marks R
Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
Cossmann M; Welzel J
Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
[TBL] [Abstract][Full Text] [Related]
5. Measurement of dermal thickness with the Harpenden skinfold caliper.
Dykes PJ; Francis AJ; Marks R
Arch Dermatol Res (1975); 1976 Oct; 256(3):261-3. PubMed ID: 984877
[TBL] [Abstract][Full Text] [Related]
6. Steroid atrophy--a histological appraisal.
Jones EW
Dermatologica; 1976; 152 Suppl 1():107-15. PubMed ID: 133833
[TBL] [Abstract][Full Text] [Related]
7. A study of potential skin atrophy following topical application of weak corticosteroids.
Black MM; Platt NE; Mugglestone CJ
Curr Med Res Opin; 1981; 7(7):463-70. PubMed ID: 7261664
[TBL] [Abstract][Full Text] [Related]
8. The measurement of corticosteroid induced dermal atrophy by a radiological method.
Marks R; Dykes PJ; Roberts E
Arch Dermatol Res (1975); 1975 Sep; 253(2):93-6. PubMed ID: 1190837
[TBL] [Abstract][Full Text] [Related]
9. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
Serup J; Holm P
Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
[TBL] [Abstract][Full Text] [Related]
10. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
Young JM; Yoxall BE; Wagner BM
Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
[TBL] [Abstract][Full Text] [Related]
11. Quantifying anti-inflammatory agents' potency by measurement of response to dinitrochlorobenzene challenge.
Rees JL; Matthews JN; Friedmann PS
J Dermatol Sci; 1992 Jul; 4(1):1-5. PubMed ID: 1390452
[TBL] [Abstract][Full Text] [Related]
12. [Development and regression of dermal corticosteroid atrophy. 1. Change in the skinfold thickness].
Lubach D; Hinz E
Derm Beruf Umwelt; 1986; 34(5):146-9. PubMed ID: 2947794
[TBL] [Abstract][Full Text] [Related]
13. Steroid-induced atrophy in an animal and human model.
Kirby JD; Munro DD
Br J Dermatol; 1976 Mar; 94 suppl 12():111-9. PubMed ID: 1268071
[TBL] [Abstract][Full Text] [Related]
14. Assessment of atrophogenicity of popularly prescribed topical corticosteroids.
Dykes PJ; Marks R; Blakemore CB
Br J Clin Pract; 1978 Dec; 32(12):345-8. PubMed ID: 737113
[No Abstract] [Full Text] [Related]
15. The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids.
van den Hoven WE; van den Berg TP; Korstanje C
Acta Derm Venereol; 1991; 71(1):29-31. PubMed ID: 1676210
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of glucocorticoid-induced skin atrophy: topical glucocorticoid apparently decreases both collagen synthesis and the corresponding collagen mRNA level in human skin in vivo.
Oikarinen A; Haapasaari KM; Sutinen M; Tasanen K
Br J Dermatol; 1998 Dec; 139(6):1106-10. PubMed ID: 9990383
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid-induced dermal atrophy in the rat.
Young JM; Yoxall BE; Wagner BM
J Invest Dermatol; 1977 Nov; 69(5):458-62. PubMed ID: 908845
[TBL] [Abstract][Full Text] [Related]
18. The Duhring chamber assay for corticosteroid atrophy.
Frosch PJ; Behrenbeck EM; Frosch K; Macher E
Br J Dermatol; 1981 Jan; 104(1):57-65. PubMed ID: 7459270
[TBL] [Abstract][Full Text] [Related]
19. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
20. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study.
Queille-Roussel C; Paul C; Duteil L; Lefebvre MC; Rapatz G; Zagula M; Ortonne JP
Br J Dermatol; 2001 Mar; 144(3):507-13. PubMed ID: 11260007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
